Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Current Assets
Cash and cash equivalents	$ 3,666.4	$ 3,871.6
Short-term investments	785.4	955.4
Accounts receivable, net of allowances of $44.3 (2015) and $55.0 (2014)	3,513.0	3,234.6
Other receivables	558.6	566.7
Inventories	3,445.8	2,740.0
Prepaid expenses and other	604.4	560.0
Total current assets	12,573.6	11,928.3
Other Assets
Restricted cash	0.0	5,405.6
Investments	3,646.6	4,568.9
Goodwill	4,039.9	1,758.1
Other intangibles, net	5,034.8	2,884.2
Sundry	2,220.5	1,798.6
Total other assets	14,941.8	16,415.4
Property and equipment, net	8,053.5	7,963.9
Total assets	35,568.9	36,307.6
Current Liabilities
Short-term borrowings and current maturities of long-term debt	6.1	2,688.7
Accounts payable	1,338.2	1,128.1
Employee compensation	967.0	759.0
Sales rebates and discounts	2,560.1	2,068.8
Dividends payable	539.0	530.3
Income taxes payable	358.9	93.5
Other current liabilities	2,460.3	2,472.6
Total current liabilities	8,229.6	9,741.0
Other Liabilities
Long-term debt	7,972.4	5,332.8
Accrued retirement benefits	2,160.3	2,562.9
Long-term income taxes payable	868.9	998.5
Other noncurrent liabilities	1,747.4	2,284.3
Total other liabilities	12,749.0	11,178.5
Eli Lilly and Company Shareholders' Equity
Common stock	691.3	694.6
Additional paid-in capital	5,552.1	5,292.3
Retained earnings	16,011.8	16,482.7
Employee benefit trust	(3,013.2)	(3,013.2)
Accumulated other comprehensive loss	(4,580.7)	(3,991.8)
Cost of common stock in treasury	(90.0)	(91.4)
Total Eli Lilly and Company shareholders' equity	14,571.3	15,373.2
Noncontrolling interests	19.0	14.9
Total equity	14,590.3	15,388.1
Total liabilities and equity	$ 35,568.9	$ 36,307.6